000 | 01982 a2200565 4500 | ||
---|---|---|---|
005 | 20250516020601.0 | ||
264 | 0 | _c20110616 | |
008 | 201106s 0 0 eng d | ||
022 | _a1872-6623 | ||
024 | 7 |
_a10.1016/j.pain.2010.11.031 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWei, Hong | |
245 | 0 | 0 |
_aSpinal transient receptor potential ankyrin 1 channel contributes to central pain hypersensitivity in various pathophysiological conditions in the rat. _h[electronic resource] |
260 |
_bPain _cMar 2011 |
||
300 |
_a582-591 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetanilides _xtherapeutic use |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnkyrins _xagonists |
650 | 0 | 4 |
_aCalcium Channels _xmetabolism |
650 | 0 | 4 |
_aCapsaicin _xadverse effects |
650 | 0 | 4 |
_aCholecystokinin _xadverse effects |
650 | 0 | 4 |
_aCinnamomum zeylanicum _xadverse effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aFormaldehyde _xadverse effects |
650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aN-Methylaspartate _xadverse effects |
650 | 0 | 4 |
_aPain Measurement _xmethods |
650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xcomplications |
650 | 0 | 4 |
_aPurines _xtherapeutic use |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aSleep Deprivation _xcomplications |
650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
650 | 0 | 4 | _aTRPA1 Cation Channel |
650 | 0 | 4 | _aTRPC Cation Channels |
700 | 1 | _aKoivisto, Ari | |
700 | 1 | _aSaarnilehto, Marja | |
700 | 1 | _aChapman, Hugh | |
700 | 1 | _aKuokkanen, Katja | |
700 | 1 | _aHao, Bin | |
700 | 1 | _aHuang, Jin-Lu | |
700 | 1 | _aWang, Yong-Xiang | |
700 | 1 | _aPertovaara, Antti | |
773 | 0 |
_tPain _gvol. 152 _gno. 3 _gp. 582-591 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pain.2010.11.031 _zAvailable from publisher's website |
999 |
_c20497081 _d20497081 |